NASDAQ: AIDX 20/20 Biolabs, Inc. 8-K

20/20 Biolabs slashes warrant exercise price 80% to $2.25, enabling major dilution

Filed April 28, 2026 · Period ending April 23, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade AIDX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 10:38 PM